✦ LIBER ✦

8 Gemcitabine-cisplatin as first-line treatment of non-small cell lung cancer (NSCLC): The Hungarian experience

✍ Scribed by Kovács, Gábor; Ostoros, Gyula; Gergely-Farmos, Erzsébet; Magyar, Pál; Szondy, Klara; Strausz, János; Ferenczi, Eniko˜

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2 The Hungarian experience with gemcitab

✍ Balikó, Zoltán; Sárosi, Veronika 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Gemcitabine and cisplatin as a first lin

✍ Pes̆ek, M; Eliasová, B; C̆ertíková, G 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Gemcitabine (GEM) as single agent in sec

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Second-line treatment with gemcitabine a

✍ Herrero, Carlos Camps; Noguerón Martı́nez, Esther; Jaime, Alfonso Berrocal 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 74 KB

P0021 Gemcitabine–docetaxel versus cispl

✍ Al-Gizawy, S.M.; Mostafa, H.G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Phase II study of liposomal cisplatin (L

✍ Mylonakis, N.; Athanasiou, A.; Ziras, N.; Angel, J.; Rapti, A.; Lampaki, S.; Pol 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 506 KB